Byung Soo Youn

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Osteoneurogen Inc., Komed Co., Ltd., Other. Active years: 2004-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Byung Soo Youn. Retrieved from https://idiyas.com/inventor/byung-soo-youn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

1 out of 834,570

Other

patents

Years Active: 2004-2022

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11298353 - Anti-inflammatory composition (2022-04-12),

2. 10744114 - Use of eupatilin as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity (2020-08-18),

3. 10744113 - Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity (2020-08-18),

4. 10370364 - Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis (2019-08-06),

5. 7390489 - Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody (2008-06-24),

6. 6692735 - Variant of C6 &bgr;-chemokine leukotactin-1(shLkn-1) with enhanced biological activity (2004-02-17),

Title: Byung Soo Youn: Innovator in Anti-Inflammatory and Fibrosis Treatments

Introduction

Byung Soo Youn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compositions and treatments for fibrosis. With a total of 6 patents to his name, Youn's work is recognized for its innovative approaches to complex medical challenges.

Latest Patents

Youn's latest patents include an anti-inflammatory composition that effectively inhibits inflammatory responses. This composition contains a compound represented by a specific formula, which targets the interaction between CD14 and LPS, blocking the expression of key inflammatory factors such as TNFα and IL-1β. Additionally, he has developed a pharmaceutical composition utilizing a chromone derivative that prevents and treats fibrosis by inhibiting epithelial-mesenchymal transition (EMT), thereby suppressing diseases caused by organ or tissue fibrosis.

Career Highlights

Throughout his career, Byung Soo Youn has worked with notable companies, including Osteoneurogen Inc. and Komed Co., Ltd. His expertise in pharmaceutical innovation has positioned him as a key figure in the development of effective treatments for inflammatory and fibrotic conditions.

Collaborations

Youn has collaborated with several professionals in his field, including Han Soo Kim and Ho Sup Yoon. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Byung Soo Youn's contributions to the pharmaceutical industry through his innovative patents highlight his commitment to improving health outcomes. His work in anti-inflammatory and fibrosis treatments continues to pave the way for future advancements in medical science.

Profile summary based on public USPTO records.